Get startedLog in
    Picture of Shengtai Pharmaceutical logo

    SGTI — Shengtai Pharmaceutical Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Shengtai Pharmaceutical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

    2012
    June 30th
    Period Length:12 M
    Source:10-K
    Standards:
    USG
    Status:Final
    Net Income/Starting Line1.07
    Depreciation
    Amortisation
    Non-Cash Items-0.834
    Other Non-Cash Items
    Changes in Working Capital-32
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Cash from Operating Activities-23.7
    Capital Expenditures-0.137
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-1.52
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-1.66
    Financing Cash Flow Items-4.11
    Other Financing Cash Flow
    Net Issuance / Retirement of Debt
    Cash from Financing Activities26.1
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.852